Donald Y M Leung Selected Research

Egg Hypersensitivity (Egg Allergy)

1/2022	Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
10/2020	Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
1/2019	The Consortium for Food Allergy Research (CoFAR): The first generation.
1/2018	Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy.
5/2010	Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy.
2/2009	Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donald Y M Leung Research Topics

Disease

76	Atopic Dermatitis (Atopic Eczema) 11/2022 - 01/2002
35	Asthma (Bronchial Asthma) 01/2022 - 08/2002
26	Inflammation (Inflammations) 01/2021 - 01/2002
23	Food Hypersensitivity (Food Allergy) 01/2022 - 12/2003
23	Infections 01/2022 - 10/2002
17	Hypersensitivity (Allergy) 11/2020 - 07/2004
14	Kaposi Varicelliform Eruption (Eczema Herpeticum) 01/2021 - 02/2004
14	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 03/2003
14	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2017 - 01/2002
12	Anaphylaxis (Anaphylactic Shock) 02/2015 - 03/2003
9	Skin Diseases (Skin Disease) 01/2021 - 04/2004
7	Eczema 01/2020 - 06/2008
7	Septic Shock (Toxic Shock Syndrome) 01/2019 - 11/2002
6	Egg Hypersensitivity (Egg Allergy) 01/2022 - 02/2009
5	Chronic Urticaria 01/2017 - 01/2010
5	Drug Hypersensitivity (Drug Allergy) 02/2015 - 07/2004
4	Neoplasms (Cancer) 10/2021 - 09/2009
4	Milk Hypersensitivity (Milk Allergy) 10/2016 - 07/2005
3	Vaccinia 01/2022 - 09/2002
3	Virus Diseases (Viral Diseases) 01/2022 - 03/2012
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 06/2002
3	Dysbiosis 09/2019 - 05/2018
3	Eosinophilic Esophagitis 01/2019 - 06/2007
3	Urticaria (Hives) 06/2014 - 06/2008
2	Hypotension (Low Blood Pressure) 04/2020 - 07/2005
2	Overweight 03/2016 - 10/2008
2	Venom Hypersensitivity 02/2015 - 02/2014
2	Respiratory Hypersensitivity 01/2012 - 04/2010
2	Angioedema 02/2009 - 06/2008

Drug/Important Bio-Agent (IBA)

27	Immunoglobulin E (IgE)IBA 11/2020 - 01/2002
21	CytokinesIBA 01/2021 - 01/2002
20	AllergensIBA 01/2022 - 07/2005
19	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 08/2002
18	Filaggrin ProteinsIBA 01/2022 - 07/2007
14	SuperantigensIBA 01/2021 - 06/2002
13	SteroidsIBA 10/2021 - 08/2002
12	Antimicrobial PeptidesIBA 09/2019 - 10/2002
12	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
12	GlucocorticoidsIBA 10/2014 - 08/2002
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2008
8	Biological ProductsIBA 11/2020 - 11/2002
8	Vitamin D FDA LinkGeneric 06/2014 - 02/2009
8	Messenger RNA (mRNA)IBA 06/2014 - 01/2002
7	Interleukin-13IBA 01/2021 - 01/2002
7	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2002
7	Enterotoxins (Enterotoxin)IBA 01/2019 - 11/2002
6	ChemokinesIBA 01/2021 - 07/2005
6	EpitopesIBA 11/2020 - 07/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 06/2014 - 03/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2003
5	Interleukin-8 (Interleukin 8)IBA 10/2020 - 09/2003
5	VaccinesIBA 01/2019 - 09/2002
5	Calcineurin InhibitorsIBA 09/2017 - 03/2003
5	anti-IgE antibodiesIBA 06/2008 - 03/2003
5	CathelicidinsIBA 12/2007 - 02/2004
5	beta-DefensinsIBA 07/2007 - 10/2002
4	LipidsIBA 11/2022 - 07/2005
4	Immune Checkpoint InhibitorsIBA 06/2022 - 11/2020
4	EmollientsIBA 01/2020 - 03/2015
4	RNA (Ribonucleic Acid)IBA 01/2018 - 10/2014
4	Virulence Factors (Pathogenicity Factors)IBA 11/2016 - 11/2002
4	Antiviral Agents (Antivirals)IBA 02/2014 - 11/2009
4	glucocorticoid receptor betaIBA 10/2010 - 08/2002
3	Staphylococcal enterotoxin FIBA 01/2021 - 11/2016
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019 - 08/2002
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2013
3	InterferonsIBA 12/2015 - 05/2013
3	Penicillins (Penicillin)FDA Link 02/2015 - 07/2004
3	Platelet Activating FactorIBA 02/2015 - 01/2010
3	Interleukin-10 (Interleukin 10)IBA 03/2014 - 10/2005
3	Omalizumab (Xolair)FDA Link 02/2014 - 01/2010
3	staphylococcal enterotoxin BIBA 01/2010 - 01/2002
3	Peptides (Polypeptides)IBA 10/2005 - 10/2002
2	AntigensIBA 01/2022 - 11/2020
2	CeramidesIBA 01/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2016
2	Urocanic AcidIBA 01/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 12/2007
2	Irritants (Vesicants)IBA 09/2017 - 06/2008
2	Histamine Antagonists (Antihistamines)IBA 01/2017 - 01/2010
2	Thymic Stromal LymphopoietinIBA 04/2016 - 06/2010
2	Interferon-gamma (Interferon, gamma)IBA 01/2016 - 12/2002
2	hydroxide ionIBA 06/2014 - 04/2010
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2013 - 06/2007
2	Arthropod VenomsIBA 01/2012 - 07/2004
2	Protein Isoforms (Isoforms)IBA 10/2010 - 08/2002
2	Mitogen-Activated Protein Kinase PhosphatasesIBA 04/2010 - 09/2009
2	Tryptases (Tryptase)IBA 01/2010 - 07/2007
2	VenomsIBA 01/2010 - 07/2004
2	staphylococcal enterotoxin CIBA 01/2010 - 05/2008
2	OvalbuminIBA 09/2009 - 12/2007
2	Interleukin-17 (Interleukin 17)IBA 09/2009 - 04/2003
2	Prednisone (Sone)FDA LinkGeneric 09/2008 - 11/2007
2	Tissue Inhibitor of MetalloproteinasesIBA 09/2008 - 11/2007
2	Tissue Inhibitor of Metalloproteinase-1IBA 09/2008 - 11/2007

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2002
14	Immunotherapy 01/2022 - 02/2009
4	Surgical Tape 01/2021 - 01/2018
2	Precision Medicine 01/2022 - 12/2021
2	Biological Therapy 01/2021 - 01/2016